Retransplantation of discordant xenogeneic islets with costimulatory blockade.

Transplant Proc

Division of Surgical Research, Department of Surgery, University Hospital Geneva, Geneva, Switzerland.

Published: May 2004

Background: The aim of the study was to analyze the possibility of xenogeneic islet retransplantation using costimulatory blockade.

Methods: Streptozotocin-induced diabetic mice were transplanted under the kidney capsule with human islets. Mice were nephrectomized and retransplanted with 1000 human islets under the contralateral kidney capsule 14 days later. Four groups were performed group I, first and second Tx without MR1; group II, first Tx without MR1, second Tx with MR1; group III, first Tx with MR1, second Tx without MR1; group IV, first and second Tx with MR1. A control group was transplanted only once without MR1 with human islets. After second Tx, cross-matches between recipient, serum and human lymphocyte were done for detection of antidonor antibodies.

Results: In the control group, mean graft survival was 13 (+/-7) days. In group I, mean graft survival was 5 +/- 3 days. In group II, mean graft survival was 16 +/- 13 days. In group III, mean graft survival was 81 +/- 22 days. In group IV, no rejection were recorded and all graft survived more than 120 days. Pretransplant cross-matches were negative. In groups I and II all cross-matches were positive, while none were positive in group IV.

Conclusion: Retransplantation of xenogeneic islets was associated with accelerated rejection. After presensitization, MR1 was unable to induce tolerance to a second Tx. MR1 given at the first Tx only allowed prolonged survival of the second Tx, but rejection still occurred. MR1 given at first and second Tx allowed long-term survival of retransplanted xenoislets and prevented occurrence of antidonor antibodies.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.transproceed.2004.05.024DOI Listing

Publication Analysis

Top Keywords

second mr1
20
graft survival
16
days group
16
human islets
12
mr1 group
12
mr1 second
12
group graft
12
survival +/-
12
+/- days
12
group
11

Similar Publications

Glycosylphosphatidylinositol (GPI) biosynthesis defect 11 (GPIBD11), part of the heterogeneous group of congenital disorders of glycosylation, is caused by biallelic pathogenic variants in . This rare disorder has previously been described in only 12 patients. We report four novel patients: two sib fetuses with congenital anomalies affecting several organs, including the heart; a living girl with tetralogy of Fallot, global developmental delay, behavioral abnormalities, and atypic electroencephalography (EEG) without epilepsy; a girl with early-onset, treatment-resistant seizures, developmental regression, and recurrent infections, that ultimately passed away prematurely due to pneumonia.

View Article and Find Full Text PDF

Implementation of the mini-CEX in a paediatric emergency department.

An Pediatr (Engl Ed)

December 2024

Servicio de Urgencias Pediátricas, Hospital Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain; Influencia del entorno en el bienestar del niño y del adolescente. Institut de Recerca Sant Joan de Déu, Esplugues de Llobregat, Barcelona, Spain; Universitat de Barcelona, Barcelona, Spain.

Article Synopsis
  • The mini-CEX is an observation tool used to evaluate and provide feedback on the care delivery skills of medical residents, which has been verified for its effectiveness in various settings, but not extensively in pediatric emergency care.
  • The study aimed to track the development of emergency care skills in pediatric residency over four years and evaluate participants' satisfaction with the mini-CEX process.
  • Results showed significant improvement in skill acquisition from year one to year two of residency, with high satisfaction ratings from both residents and evaluators, indicating a successful implementation of the mini-CEX.
View Article and Find Full Text PDF

Removal of Acid Red 88 (AR88) as an azo dye from the synthetic type of wastewater was studied in a laboratory-made constructed wetland microbial fuel cell (CW-MFC) inoculated with Shewanella oneidensis MR-1 (SOMR-1). Plant cultivation was implemented using a typical CW plant known as Cyperus alternifolius. The complexity of the SOMR-1 cell membrane having different carriers of electrons and H ions gives the microbe special enzymatic ability to participate in the AR88 oxidation link to the O reduction.

View Article and Find Full Text PDF

Introduction: The uptake trend of a new vaccine is unpredictable and may reflect the quality of introduction process and community acceptance. The objective of this study was to conduct a trend analysis of RTS,S malaria vaccine uptake in the seven pilot regions of Ghana from 2019 to 2022. The findings are envisaged to strengthen malaria vaccine introductions in the future.

View Article and Find Full Text PDF

Engineering Shewanella oneidensis-Carbon Felt Biohybrid Electrode Decorated with Bacterial Cellulose Aerogel-Electropolymerized Anthraquinone to Boost Energy and Chemicals Production.

Adv Sci (Weinh)

October 2024

Frontier Science Center for Synthetic Biology (Ministry of Education), Key Laboratory of Systems Bioengineering, and School of Chemical Engineering and Technology, Tianjin University, Tianjin, 300072, China.

Interfacial electron transfer between electroactive microorganisms (EAMs) and electrodes underlies a wide range of bio-electrochemical systems with diverse applications. However, the electron transfer rate at the biotic-electrode interface remains low due to high transmembrane and cell-electrode interfacial electron transfer resistance. Herein, a modular engineering strategy is adopted to construct a Shewanella oneidensis-carbon felt biohybrid electrode decorated with bacterial cellulose aerogel-electropolymerized anthraquinone to boost cell-electrode interfacial electron transfer.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!